Free Lecture at Nettetal Hospital Explores Early Heart Disease Detection
Free Lecture at Nettetal Hospital Explores Early Heart Disease Detection
Free Lecture at Nettetal Hospital Explores Early Heart Disease Detection
A free public lecture on diagnosing coronary artery disease (CAD) will take place at Nettetal Hospital on February 4. The event, led by Dr. Peter Leven, will focus on non-surgical methods for detecting the condition early. CAD remains a leading cause of heart-related health issues, often leading to severe complications if untreated.
CAD develops when fatty deposits, blood clots, and connective tissue build up inside the coronary arteries. This buildup narrows the vessels, reducing blood flow to the heart. A common warning sign is angina pectoris—a tightness or pressure in the chest that flares up during physical activity.
Dr. Peter Leven, Chief Physician of Cardiology and Pneumology at Nettetal Hospital, will explain how early detection can prevent life-threatening outcomes like heart attacks. His talk, scheduled for 3:00 PM, will highlight stress echocardiography as a dependable and low-risk alternative to invasive procedures such as cardiac catheterization. The lecture aims to inform the public about modern diagnostic options. Attendees will learn how these methods can improve early intervention and patient outcomes.
The session offers a chance for the community to understand CAD and its non-surgical diagnostic approaches. Dr. Leven's presentation will take place in the hospital's lecture hall, providing clear, practical information for those concerned about heart health.
Garlic, Vitamin C, and Chlorophyll Team Up for Heart Health Breakthrough
Could a simple blend of garlic, vitamin C, and chlorophyll be the key to a healthier heart? New findings reveal surprising benefits for blood pressure and beyond.
Chuck Norris, 86, hospitalized after medical emergency in Hawaii
From Walker, Texas Ranger to recent films, Norris never slowed down—until now. Fans worldwide await news after his sudden hospitalization.
Blood Test Breakthrough Could Detect Hidden Artery Disease Years Earlier
A simple blood test could soon reveal invisible plaque buildup—long before it triggers a deadly event. Machine learning cracked the code in 45,000 patients' data.
Eli Lilly's retatrutide shows groundbreaking results in Type 2 diabetes trial
A triple-hormone drug could redefine diabetes care. Early data shows retatrutide outperforms competitors—but will regulators agree?